SCHEMBL1664587

SCHEMBL1664587

O=C(Nc1ccc(-n2ncc3cc(Nc4ccc(N5CCCC(O)C5)cc4)ccc32)cc1)c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.48
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
GAA P10253 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
USP2 O75604 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 2/20 0.42
ALOX12 P18054 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PDE7A Q13946 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664235 0.95 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664591 0.93 MAPT (0.47) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1666799 0.90 MAPT (0.53) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1665038 0.88 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664237 0.88 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1666916 0.88 MAPT (0.52) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1666114 0.85 MAPT (0.51) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL6125796 0.84 MAPT (0.50) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664395 0.84 MAPT (0.50) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664696 0.83 MCHR1 (0.52) MAPTRAB9ANPC1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed